More recent studies have shown that in cancer cells, ACSS2 is expressed in cell nuclei, where it operates to recycle acetate derived from HDAC-mediated deacetylation reactions during hypoxia (Bulusu et al., 2017). The gene discussed is ACSS2; the disease is cancer.